The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it hold, with a mean price target of $71.
Moelis & Company
MC · the NYSE · USD · Market cap $4.8B · 1,416 employees
Moelis & Company operates as an investment banking advisory company in North and South America, Europe, the Middle East, Asia, and Australia.
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Moelis & Company holds its Distribution at $64.25. The statistical read favours the sellers, held for 262 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 262 days |
| Price at the screen | $64.25 |
| Valuation | 22.39 trailing · 16.38 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.84 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: financial services | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 1.4% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus None. The average target sits +11% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAdvisory fees look tempting until ethics bite
Picture a banker in New York closing a merger that moves billions across borders. The fees land quickly, yet the whole sector sits on our prohibited list because financial services carry risks we will not touch.
We pass for the clearest reason: the ethical screen fails outright on industry grounds. Revenue growth sits at just 4 percent, the forward multiple is 17.3 times, and the shares already trade above our fair value with almost no margin of safety. High return on equity of 42 percent cannot override that hard stop.
The business remains exposed to deal cycles that can flatten fast, and analyst targets offer little comfort when the core objection is ethical. A hold consensus does not change the screen result.
Analysis, not advice.
| Forward P/E | 16.4xpriced for continued growth |
| Trailing P/E | 22.4xa premium valuation |
| EPS, trailing | 2.87 |
| EPS, forward | 3.92 |
| Revenue growth | +12.0%steady growth |
| Profit margin | 14.5%thin but positive margins |
| Return on equity | 41.5%an exceptional return on shareholder capital |
| Dividend yield | 384.00% |
| Debt to equity | 0.41minimal debt: a conservative balance sheet |
| Current ratio | 1.17adequate liquidity, worth monitoring |
| Beta | 1.84much more volatile than the market |
| Short interest, float | 0.08% |
| 52-week range | 51.06 - 78.22 |
| Market cap | $4.8B |
| Employees | 1,416 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it hold, with a mean price target of $71.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it hold, with a mean price target of $71.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 May2026 | Mike Kelly | Republican | sell | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Jul2026 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $63.85 | +5.1% | $0.65 | $1,061 | +6.1% |
| 2 months | $62.41 | +7.5% | $0.65 | $1,086 | +8.6% |
| 3 months | $50.87 | +31.9% | $0.65 | $1,332 | +33.2% |
| 6 months | $69.58 | -3.6% | $1.30 | $983 | -1.7% |
| 1 year | $55.54 | +20.8% | $2.60 | $1,255 | +25.5% |
| 2 years | $48.79 | +37.5% | $5.10 | $1,480 | +48.0% |
| 3 years | $37.94 | +76.9% | $7.50 | $1,966 | +96.6% |
| 5 years | $41.93 | +60.0% | $14.80 | $1,953 | +95.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.